Peripheral excitatory amino acids

Susan M. Carlton

    Research output: Contribution to journalArticle

    141 Citations (Scopus)

    Abstract

    Glutamate receptors (GluRs) are localized in the periphery on nociceptive primary afferent terminals. Studies in animal models of pain demonstrate that peripheral glutamate is involved in nociceptive transmission in the normal and the inflamed state and that modulation of peripheral GluRs reduces pain behaviors and nociceptor activity. These data provide strong motivation to develop new pharmacological agents that will target peripheral GluRs, offering novel approaches to treatment of pain of peripheral origin.

    Original languageEnglish
    Pages (from-to)52-56
    Number of pages5
    JournalCurrent Opinion in Pharmacology
    Volume1
    Issue number1
    DOIs
    StatePublished - Feb 1 2001

    Fingerprint

    Excitatory Amino Acids
    Glutamate Receptors
    Pain
    Nociceptors
    Motivation
    Glutamic Acid
    Animal Models
    Pharmacology
    Therapeutics

    Keywords

    • Glutamate
    • Inflammation
    • Nociception
    • Nociceptors
    • Primary afferents
    • Sensory neurons
    • Sympathetic system

    ASJC Scopus subject areas

    • Cellular and Molecular Neuroscience
    • Pharmacology

    Cite this

    Peripheral excitatory amino acids. / Carlton, Susan M.

    In: Current Opinion in Pharmacology, Vol. 1, No. 1, 01.02.2001, p. 52-56.

    Research output: Contribution to journalArticle

    Carlton, Susan M. / Peripheral excitatory amino acids. In: Current Opinion in Pharmacology. 2001 ; Vol. 1, No. 1. pp. 52-56.
    @article{8594b5b42e7345edaa5073940bd8884f,
    title = "Peripheral excitatory amino acids",
    abstract = "Glutamate receptors (GluRs) are localized in the periphery on nociceptive primary afferent terminals. Studies in animal models of pain demonstrate that peripheral glutamate is involved in nociceptive transmission in the normal and the inflamed state and that modulation of peripheral GluRs reduces pain behaviors and nociceptor activity. These data provide strong motivation to develop new pharmacological agents that will target peripheral GluRs, offering novel approaches to treatment of pain of peripheral origin.",
    keywords = "Glutamate, Inflammation, Nociception, Nociceptors, Primary afferents, Sensory neurons, Sympathetic system",
    author = "Carlton, {Susan M.}",
    year = "2001",
    month = "2",
    day = "1",
    doi = "10.1016/S1471-4892(01)00002-9",
    language = "English",
    volume = "1",
    pages = "52--56",
    journal = "Current Opinion in Pharmacology",
    issn = "1471-4892",
    publisher = "Elsevier BV",
    number = "1",

    }

    TY - JOUR

    T1 - Peripheral excitatory amino acids

    AU - Carlton, Susan M.

    PY - 2001/2/1

    Y1 - 2001/2/1

    N2 - Glutamate receptors (GluRs) are localized in the periphery on nociceptive primary afferent terminals. Studies in animal models of pain demonstrate that peripheral glutamate is involved in nociceptive transmission in the normal and the inflamed state and that modulation of peripheral GluRs reduces pain behaviors and nociceptor activity. These data provide strong motivation to develop new pharmacological agents that will target peripheral GluRs, offering novel approaches to treatment of pain of peripheral origin.

    AB - Glutamate receptors (GluRs) are localized in the periphery on nociceptive primary afferent terminals. Studies in animal models of pain demonstrate that peripheral glutamate is involved in nociceptive transmission in the normal and the inflamed state and that modulation of peripheral GluRs reduces pain behaviors and nociceptor activity. These data provide strong motivation to develop new pharmacological agents that will target peripheral GluRs, offering novel approaches to treatment of pain of peripheral origin.

    KW - Glutamate

    KW - Inflammation

    KW - Nociception

    KW - Nociceptors

    KW - Primary afferents

    KW - Sensory neurons

    KW - Sympathetic system

    UR - http://www.scopus.com/inward/record.url?scp=0035258219&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0035258219&partnerID=8YFLogxK

    U2 - 10.1016/S1471-4892(01)00002-9

    DO - 10.1016/S1471-4892(01)00002-9

    M3 - Article

    VL - 1

    SP - 52

    EP - 56

    JO - Current Opinion in Pharmacology

    JF - Current Opinion in Pharmacology

    SN - 1471-4892

    IS - 1

    ER -